| Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial 2014 · prebiotic group · Preterm infants born at 32+0 to 36+6 weeks' gestation, recruited on days 1–3 of life | 600 mg | 60 days | 23 |
| Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study 2024 · 1-kestose administration group · Adults aged 20–80 with untreated, unresectable pancreatic ductal adenocarcinoma receiving chemotherapy | 9 g | 12 weeks | 20 |
| Effects of Bifidobacterium lactis HN019 and prebiotic oligosaccharide added to milk on iron status, anemia, and growth among children 1 to 4 years old 2010 · probiotic- and prebiotic-fortified milk · Children aged 1 to 4 years in a periurban community | 2.4 g | 1 year | 312 |
| Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial 2010 · Prebiotic and probiotic fortified milk (PP) · Children aged 1–4 years in a community setting in India, with no specific diagnosed condition required | 2.4 g | 1 year | 312 |
| Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial 2018 · Synbiotics group · Patients older than 16 years with sepsis requiring mechanical ventilation in the ICU | 10 g | 20 days | 35 |
| Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial 2024 · Synbiotic group (Pro) · Adult women with histologically confirmed, non-metastatic primary invasive breast cancer who were candidates for neoadjuvant therapy | 38.5 mg | 18 weeks | 21 |
| Exploring the synergistic effects of vitamin D and synbiotics on cytokines profile, and treatment response in breast cancer: a pilot randomized clinical trial 2024 · Vitamin D + synbiotic group (VitD + Pro) · Adult women with histologically confirmed, non-metastatic primary invasive breast cancer who were candidates for neoadjuvant therapy | 38.5 mg | 18 weeks | 18 |
| Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial 2008 · synbiotic group · Newborn infants at high risk for allergy | 800 mg | 26 weeks | — |
| Follow-up formula consumption in 3- to 4-year-olds and respiratory infections: an RCT 2014 · FUF group · Healthy children aged 3–4 years | 3.6 g | 28 weeks | — |
| Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants 2017 · FeGOS group · Kenyan infants aged 6.5–9.5 months | 7.5 g | 120 days | — |
| Effect of a prebiotic galactooligosaccharide mixture (B-GOS®) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence 2018 · B-GOS® treatment · Adults from the general population with gastrointestinal symptoms and a predicted probability of functional bowel disorder greater than 75% | 2.75 g | 2 weeks | 83 |
| Effects of Yeast Mannan Which Promotes Beneficial Bacteroides on the Intestinal Environment and Skin Condition: A Randomized, Double-Blind, Placebo-Controlled Study 2020 · YM group · Healthy women aged 30–49 years who were aware of skin dryness and had stable menstrual periods | 1.1 g | 8 weeks | 55 |
| Prebiotic effect of two grams of lactulose in healthy Japanese women: a randomised, double-blind, placebo-controlled crossover trial 2019 · lactulose · Healthy Japanese women with defaecation frequency of 2–4 times per week | 2 g | 2 weeks | 52 |
| Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial 2024 · Prefrail prebiotic intervention group · Community-dwelling men and women over 65 years old who were prefrail | 15 g | 12 weeks | 50 |
| Prebiotics improve frailty status in community-dwelling older individuals in a double-blind, randomized, controlled trial 2024 · Frail prebiotic intervention group · Community-dwelling men and women over 65 years old who were frail | 15 g | 12 weeks | 50 |
| Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial 2022 · 5.5 g GOS · Adults aged 18–56 with self-reported constipation | 5.5 g | 3 weeks | 45 |
| Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial 2022 · 11 g GOS · Adults aged 18–56 with self-reported constipation | 11 g | 3 weeks | 44 |
| Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea a randomized clinical trial 2022 · Triphala group · Participants aged 14–50 years with scalp seborrhea | 2 g | 8 weeks | 40 |
| Improvement of sleep by resistant dextrin prebiotic in type 2 diabetic women coincides with attenuation of metabolic endotoxemia: involvement of gut-brain axis 2022 · intervention group · Obese women with type 2 diabetes | 10 g | 8 weeks | 38 |
| Impact of dietary supplementation with resistant dextrin (NUTRIOSE(®)) on satiety, glycaemia, and related endpoints, in healthy adults 2021 · resistant dextrin (RD) treatment · Healthy adults aged 22–55 years, normal weight or overweight | 14 g | 4 weeks | 36 |
| Effectiveness of Partially Hydrolyzed Guar Gum on Cognitive Function and Sleep Efficiency in Healthy Elderly Subjects in a Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Study 2024 · PHGG group (test food group) · Healthy Japanese men and women aged over 60 years, with MMSE-J score of at least 24 and relatively low gait speed | 5 g | 12 weeks | 30 |
| Indicators of improved emotion behavior in 6-14-year-old children following a 4-week placebo controlled prebiotic supplement intervention at home with a parent 2025 · GOS group · Healthy children aged 6–14 years without current clinical anxiety, psychological diagnoses, developmental disorders, gastrointestinal problems or restrictive diets; girls and boys | 5.5 g | 4 weeks | 28 |
| The Effects of Agave Fructans in a Functional Food Consumed by Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial 2023 · experimental group · Adults, average age 50 years, mostly women, with constipation-predominant irritable bowel syndrome | 7.8 g | 30 days | 25 |
| Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit 2020 · AXOS · Healthy men and women aged 20–55 years with slow gastrointestinal transit and no constipation | 15 g | 12 weeks | 24 |
| β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria 2020 · LFD/B-GOS · Adults with Rome III irritable bowel syndrome recruited from secondary care in the United Kingdom | 1.4 g | 4 weeks | 24 |
| Faecal and urine metabolites, but not gut microbiota, may predict response to low FODMAP diet in irritable bowel syndrome 2023 · LFD/B-GOS · Adults meeting Rome III criteria for irritable bowel syndrome | 1.8 g | 4 weeks | 24 |
| Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study 2025 · 2FL + placebo · Adults aged 18–90 with a diagnosed primary Parkinsonian syndrome and moderate disease severity | 3.9 g | 26 weeks | 23 |
| A Double-Blind Randomised Controlled Trial of Prebiotic Supplementation in Children with Autism: Effects on Parental Quality of Life, Child Behaviour, Gastrointestinal Symptoms, and the Microbiome 2025 · GOS (prebiotic) group · Children aged 4–10 years with an existing diagnosis of autism; sex not restricted | 2.4 g | 6 weeks | 22 |
| Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial 2024 · Group 1: AF 5 g (Predilife) · Adults with functional constipation; age and sex range not reported | 5 g | 8 weeks | 21 |
| Effects of Human Milk Oligosaccharide 2'-Fucosyllactose Ingestion on Weight Loss and Markers of Health 2024 · 2′-FL group · Men and women aged 18–65 with overweight or obesity (BMI 25–40 kg/m² and/or body fat above 30%), beginning a weight-loss and walking program | 3 g | 12 weeks | 21 |
| Effect of a prebiotic mixture on intestinal comfort and general wellbeing in health 2008 · FOS · Healthy volunteers aged 20–37 years, male and female | 10 g | 5 weeks | 20 |
| Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: a randomised, placebo-controlled cross-over study 2010 · AXOS · Healthy adults; age and sex not reported | 10 g | 3 weeks | 20 |
| Effects of Prebiotic Yeast Mannan on Gut Health and Sleep Quality in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study 2023 · YM group · Healthy Japanese adults aged 20–64 with discomfort in defecation | 1.1 g | 4 weeks | 20 |
| A low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects 2018 · Oligofructose · Healthy adults aged 18 years or older; both sexes; no stated gastrointestinal disorder | 14 g | 7 days | 19 |
| A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammation 2016 · B-GOS · Adults with asthma and hyperpnoea-induced bronchoconstriction, and control adults without asthma; age and sex not reported | 5.5 g | 3 weeks | 18 |
| Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial 2024 · Group 2: AF 10 g (Predilife) · Adults with functional constipation; age and sex range not reported | 10 g | 8 weeks | 18 |
| Daily consumption of galactooligosaccharide gummies ameliorates constipation symptoms, gut dysbiosis, degree of depression and quality of life among sedentary university teaching staff: A double-blind randomized placebo control clinical trial 2023 · experimental group · Sedentary adults with functional constipation; age range and sex not stated | 10 g | 30 days | 17 |
| Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men 2006 · 30 g NUTRIOSE FB group · Healthy men; age and BMI reported for the study group as a whole, not by arm | 30 g | 5 weeks | 16 |
| Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men 2006 · 45 g NUTRIOSE FB group · Healthy men; age and BMI reported for the study group as a whole, not by arm | 45 g | 5 weeks | 16 |
| Comparison of the Effects of Prebiotics and Synbiotics Supplementation on the Immune Function of Male University Football Players 2023 · prebiotic group (PG) · Male university football players; age not reported; healthy student-athletes undergoing high-intensity training | 2 g | 6 weeks | 15 |
| The effect of arabinoxylooligosaccharides on gastric sensory-motor function and nutrient tolerance in man 2016 · AXOS · Healthy volunteers, 32.2 ± 1.8 years, 6 male; no stated condition | 37.6 g | 2 days | 13 |
| A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of 1-Kestose on Defecation Habits in Constipated Kindergarten Children: A Pilot Study 2023 · kestose group · Kindergarten children with defecation on 4 or fewer days per week | 3 g | 8 weeks | 11 |
| Effects of polydextrose supplementation on different faecal parameters in healthy volunteers 2009 · polydextrose supplementation · Healthy subjects; age and sex not reported | 8 g | — | — |
| Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students 2011 · 2.5 g galactooligosaccharides · Undergraduate students experiencing academic exam stress; age and sex not specified | 2.5 g | 8 weeks | — |
| Galactooligosaccharide supplementation reduces stress-induced gastrointestinal dysfunction and days of cold or flu: a randomized, double-blind, controlled trial in healthy university students 2011 · 5.0 g galactooligosaccharides · Undergraduate students experiencing academic exam stress; age and sex not specified | 5 g | 8 weeks | — |
| Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study 2014 · XOS · Healthy adults aged 25–65 years | 8 g | 3 weeks | — |
| Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial 2016 · LU · Adults aged 18–65 with overweight or obesity (BMI 28.0–34.9) | 12 g | 26 weeks | — |
| Randomized Controlled Trial on the Effect of Partially Hydrolyzed Guar Gum Supplementation on Diarrhea Frequency and Gut Microbiome Count Among Pelvic Radiation Patients 2021 · Intervention group (IG) · Adults undergoing pelvic radiation for pelvic cancers | 20 g | 4 weeks | — |
| Effect of fructooligosaccharide on endothelial function in CKD patients: a randomized controlled trial 2021 · FOS group · Adults with nondiabetic chronic kidney disease | 12 g | 90 days | — |
| Effects of 24-week prebiotic intervention on self-reported upper respiratory symptoms, gastrointestinal symptoms, and markers of immunity in elite rugby union players 2023 · prebiotic group · Elite rugby union players; age and sex not stated. | 2.8 g | 24 weeks | — |
| Consumption of Extruded Sorghum SC319 Improved Gut Microbiota at Genus Level and Reduced Anthropometric Markers in Men with Overweight: A Randomized Controlled Clinical Trial 2023 · Extruded SC319 whole sorghum · Men aged 18–40 with overweight (BMI 27.0–34.9 kg/m²) | 40 g | 8 weeks | — |
| Cow's milk-based beverage consumption in 1- to 4-year-olds and allergic manifestations: an RCT 2016 · CMBB · Children aged 1 to 4 years attending daycare in Brazil; generally healthy, without a stated diagnosed condition | 3.6 g | 28 weeks | 125 |
| Effect of an Immune-Boosting, Antioxidant and Anti-Inflammatory Food Supplement in Hospitalized COVID-19 Patients: A Prospective Randomized Pilot Study 2023 · intervention group · Adults aged 18 years or older hospitalized with PCR-confirmed COVID-19 who required more than 48 hours of admission | 200 mg | — | 78 |
| Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial 2015 · group S (synbiotics) · Adults undergoing surgery for periampullary neoplasms; age and sex not specified | 200 mg | 2 weeks | 23 |
| Effectiveness of Sterilized Symbiotic Drink Containing Lactobacillus helveticus Comparable to Probiotic Alone in Patients with Constipation-Predominant Irritable Bowel Syndrome 2020 · Group A (symbiotic group) · Adults with constipation-predominant irritable bowel syndrome; age range not reported; both sexes | 5.85 g | 7 days | 79 |
| Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study 2023 · Synbiotic · Adults aged 18 years or older, women and men with abdominal overweight or obesity (BMI ≥25 and elevated waist circumference) | 10 g | 12 weeks | 60 |
| Probiotics combined with prebiotics alleviated seasonal allergic rhinitis by altering the composition and metabolic function of intestinal microbiota: a prospective, randomized, double-blind, placebo-controlled clinical trial 2024 · test group (probiotics and prebiotics) · Adults aged 18–65 with seasonal allergic rhinitis lasting more than 1 year and TNSS greater than 4 | 60 g | 90 days | 53 |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group A · Adults aged 18–70 with functional constipation | 7.82 g | 4 weeks | 50 |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group B · Adults aged 18–70 with functional constipation | 1.48 g | 4 weeks | 50 |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group D · Adults aged 18–70 with functional constipation | 960 mg | 4 weeks | 50 |
| Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial 2023 · Active synbiotic arm · Children aged 3–17, male and female, with variable weekly bowel movement frequency; some had low-frequency bowel movements or constipation | 6.2 g | 12 weeks | 43 |
| The promising effects of a multi-species synbiotic preparation on metabolic profile in elderly patients with type 2 diabetes and high cardiovascular risk: a randomized, triple-blind, placebo-controlled trial 2025 · Synbiotic group · Men and women aged 65 years or older with type 2 diabetes and high cardiovascular risk | 500 mg | 120 days | 43 |
| Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial 2020 · CRS group (calorie-restricted diet plus synbiotic) · Women aged 18–65 with BMI 25–35 and stage I or II breast cancer-related unilateral arm lymphedema | 38.5 mg | 10 weeks | 41 |
| Effect of a Prebiotic Formulation on Frailty Syndrome: A Randomized, Double-Blind Clinical Trial 2016 · Darmocare Pre® group · Adults aged 66–90 years living in nursing homes; participants were non-demented, able to walk, and aged 65 years or older | 3.49 g | 13 weeks | 36 |
| Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised controlled trial 2024 · Prebiotic · Adults aged 63–83 (mean 73), women and men, older healthy volunteers with previously reported low dietary protein intake | 7.5 g | 12 weeks | 36 |
| The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant Irritable Bowel Syndrome-A Randomized Double-Blind, Placebo-Controlled Study 2020 · synbiotic group · Female and male adults aged 18–60 with moderate or severe diarrhea-predominant irritable bowel syndrome (IBS-D) | 1.89 g | 8 weeks | 35 |
| The effects of synbiotics supplementation on reducing chemotherapy-induced side effects in women with breast cancer: a randomized placebo-controlled double-blind clinical trial 2023 · Synbiotics · Women aged 18 years or older with breast cancer, no metastasis, undergoing neoadjuvant or adjuvant chemotherapy | 42 g | 8 weeks | 34 |
| Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial 2025 · synbiotic group · Adults aged 60 years or older with functional constipation by Rome IV criteria and no significant comorbidities | 800 mg | 4 weeks | 34 |
| Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial 2023 · synbiotic group · Adults aged 60 years or older with irritable bowel syndrome meeting Rome IV criteria | 200 mg | 4 weeks | 33 |
| Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's disease 2025 · synbiotic group · Adults aged 45–65, both sexes, newly diagnosed with Parkinson's disease, stages 1–4 | 6 g | 90 days | 33 |
| A synbiotic mixture for the management of infantile colic: A randomized trial 2024 · Group 2 (two doses of the synbiotic combination) · Full-term, presumed healthy infants aged 2–8 weeks with symptoms suggesting infantile colic; all feeding types were allowed. | 40 mg | 4 weeks | 31 |
| Preliminary clinical study on the synergistic effects of prebiotics and β-hydroxy-β-methylbutyrate in improving muscle function and intestinal barrier function in elderly patients with sarcopenia 2026 · Group B · Adults aged 65 years or older with sarcopenia | 10 g | 30 days | 31 |
| The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial 2023 · Synbiotic group · Adults aged 25–65, women and men with subclinical hypothyroidism treated with levothyroxine | 500 mg | 10 weeks | 28 |
| Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis 2016 · synbiotic group · Adults aged 25–74 with biopsy-confirmed nonalcoholic steatohepatitis (NASH); both sexes | 8 g | 90 days | 27 |
| Effects of synbiotic supplementation on the components of metabolic syndrome in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial 2024 · Synbiotic + antipsychotic group · Adults aged 18–65 with schizophrenia, BMI ≥23 and at least two metabolic-syndrome criteria, taking antipsychotic drugs | 42 mg | 8 weeks | 27 |
| Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation 2014 · Treatment Group (TG) · Adults aged 18–45 years, both sexes, with chronic constipation | 3.6 g | 2 weeks | 26 |
| Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study 2025 · 2FL + PA + BA · Adults aged 18–90 with a diagnosed primary Parkinsonian syndrome and moderate disease severity | 3.9 g | 26 weeks | 24 |
| Effects of probiotic and synbiotic supplementation on ponderal and linear growth in severely malnourished young infants in a randomized clinical trial 2023 · Synbiotic · Infants aged 2–6 months with severe acute malnutrition, recovering from acute illness; both sexes | 3.2 g | 4 weeks | 23 |
| Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial 2023 · L-carnitine + synbiotic · Women aged 19–49 with obesity (BMI 30–35 kg/m²), without the listed comorbidities | 175 mg | 8 weeks | 23 |
| Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults?: Randomized, double-blind, placebo-controlled trial 2022 · Synbiotics · Healthy adults aged 20–60 years, men and women, with bowel movements 2–3 times per week and a tendency to constipation | 1 g | 2 weeks | 22 |
| A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study 2022 · synbiotic group · Adults with functional diarrhea and fecal calprotectin levels of at least 11.5 mg/kg; mean age 49.8 years | 2.4 g | 8 weeks | 20 |
| Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial 2024 · Group 3: AF 5 g (Predilife)+10 g maltodextrin (MTDx) · Adults with functional constipation; age and sex range not reported | 5 g | 8 weeks | 20 |
| Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study 2011 · synbiotics treatment group · Patients with mild to moderate ulcerative colitis | 5.5 g | 1 year | — |
| Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study 2014 · XOS+Bi-07 synbiotic · Healthy adults aged 25–65 years | 8 g | 3 weeks | — |
| Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults-Randomized Controlled Trial 2016 · LU + B420 · Adults aged 18–65 with overweight or obesity (BMI 28.0–34.9) | 12 g | 26 weeks | — |
| Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial 2019 · oligofructose · Individuals with liver-biopsy-confirmed NASH and NAS ≥ 5; age and sex not reported | 24 g | 36 weeks | — |
| Effect of Bacillius Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy, A Randomized-Controlled Clinical Trial 2021 · LactoWise® group (LWG) · Morbidly obese patients undergoing laparoscopic sleeve gastrectomy; age and sex not specified | 300 mg | 90 days | — |
| Effect of synbiotic and probiotic supplementation on serum brain-derived neurotrophic factor level, depression and anxiety symptoms in hemodialysis patients: a randomized, double-blinded, clinical trial 2021 · synbiotic · Hemodialysis patients; age and sex not specified | 15 g | 12 weeks | — |
| Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial 2023 · synbiotic supplementation group (SG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years | 3.4 g | 8 weeks | — |
| Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial 2023 · dietary intervention with synbiotic supplementation group (DSG) · Overweight and obese Hong Kong Chinese individuals aged 20–65 years | 3.4 g | 8 weeks | — |
| Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial 2024 · treatment arm · People diagnosed with pre-diabetes who were not receiving glucose-lowering medications; age and sex not reported | 20 g | 24 weeks | 33 |
| Is there any place for resistant starch, as alimentary prebiotic, for patients with type 2 diabetes? 2015 · intervention · Women with type 2 diabetes | 10 g | 8 weeks | 28 |
| Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods 2012 · Soy foods with prebiotic · Hypercholesterolemic men and postmenopausal women | 10 g | 30 days | — |
| The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial 2019 · prebiotic group · Women aged 18–45 with polycystic ovary syndrome | 20 g | 90 days | — |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group C · Adults aged 18–70 with functional constipation | 3.8 g | 4 weeks | 50 |
| Synbiotic as an ameliorating factor in the health-related quality of life in women with polycystic ovary syndrome. A randomized, triple-blind, placebo-controlled trial 2024 · synbiotic group · Women aged 18–45 with newly diagnosed polycystic ovary syndrome (PCOS) | 500 mg | 12 weeks | 28 |
| Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study 2019 · Prebiotic group · Adults aged 18–60 with mild constipation | 13 g | 4 weeks | 20 |
| Effects of a Synbiotic Formula on Functional Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A Pilot Study 2020 · intervention group (IG) · Bedridden adults with neurological disorders receiving long-term home enteral nutrition; average age 75.2 years | 375 mg | 120 days | 11 |
| Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study 2021 · Sedentary participants administered with the synbiotic · Sedentary male students with low physical activity (≤150 min/week) | 200 mg | 30 days | — |
| Differential Health Effects on Inflammatory, Immunological and Stress Parameters in Professional Soccer Players and Sedentary Individuals after Consuming a Synbiotic. A Triple-Blinded, Randomized, Placebo-Controlled Pilot Study 2021 · Professional soccer players administered with the synbiotic · Male professional soccer players competing in the Spanish Second Division B | 200 mg | 30 days | — |
| A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy of the synbiotic medical food, SBD111, for the clinical dietary management of bone loss in menopausal women 2025 · SBD111 · Healthy postmenopausal women 1–6 years after menopause, aged about 55 years; some had osteopenia or BMI ≥30 | 1.28 g | 1 year | 144 |
| The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial 2021 · oat group · Adults aged 18–65 with mild hypercholesterolemia | 80 g | 45 days | 94 |
| Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients 2019 · prebiotic group · Men and women aged 40–75 years with colorectal cancer undergoing perioperative care | 30 g | 7 days | 70 |
| Lactulose ingestion causes an increase in the abundance of gut-resident bifidobacteria in Japanese women: a randomised, double-blind, placebo-controlled crossover trial 2021 · lactulose ingestion · Japanese women; age and health condition not specified | 2 g | 2 weeks | 60 |
| Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal 2012 · AXOS 2.2 g/d · Healthy men and women; ages not specified | 2.2 g | 3 weeks | 55 |
| Digestive and physiologic effects of a wheat bran extract, arabino-xylan-oligosaccharide, in breakfast cereal 2012 · AXOS 4.8 g/d · Healthy men and women; ages not specified | 4.8 g | 3 weeks | 55 |
| Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention 2024 · prebiotics · Adult men and women with obesity; age range not reported | 16 g | 90 days | 51 |
| Galacto-oligosaccharides supplementation in prefrail older and healthy adults increased faecal bifidobacteria, but did not impact immune function and oxidative stress 2021 · Biotis™ GOS · 20 prefrail elderly adults and 24 healthy adults | 15 g | 4 weeks | 44 |
| Differential effects of inulin and fructooligosaccharides on gut microbiota composition and glycemic metabolism in overweight/obese and healthy individuals: a randomized, double-blind clinical trial 2025 · FOS group · Chinese adults with normal weight or overweight/obesity; adults with overweight/obesity were included alongside healthy normal-weight controls | 15 g | 4 weeks | 43 |
| A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers 2012 · AXOS-bread · Healthy adults aged 18–55 years, without chronic disease | 2.2 g | 3 weeks | 40 |
| Influence of galacto-oligosaccharide mixture (B-GOS) on gut microbiota, immune parameters and metabonomics in elderly persons 2015 · B-GOS · Volunteers aged 65–80 years | 5.5 g | 10 weeks | 40 |
| A Randomized, Double-Blind, Placebo-Controlled Trial: Efficacy of Opuntia ficus-indica Prebiotic Supplementation in Subjects with Gut Dysbiosis 2024 · Group A (active treatment arm) · Healthy males and females aged 25–50 with gut dysbiosis of unknown etiology | 300 mg | 8 weeks | 40 |
| Effects of a diverse prebiotic fibre blend on inflammation, the gut microbiota and affective symptoms in metabolic syndrome: a pilot open-label randomised controlled trial 2024 · Treatment group · Males and females aged 18–75 years who met criteria for metabolic syndrome | 10 g | 12 weeks | 40 |
| Maternal Prebiotic Ingestion Increased the Number of Fecal Bifidobacteria in Pregnant Women but Not in Their Neonates Aged One Month 2017 · FOS intake group · Healthy pregnant women; ages and sex beyond pregnancy status not reported | 8 g | — | 35 |
| Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population 2017 · GOS group · Adults aged 18–65 years, both sexes, described as healthy | 16 g | 2 weeks | 35 |
| Prebiotic effect of inulin-type fructans on faecal microbiota and short-chain fatty acids in type 2 diabetes: a randomised controlled trial 2020 · inulin-type fructans · Adult men and women with type 2 diabetes | 16 g | 6 weeks | 35 |
| Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population 2017 · FOS group · Adults aged 18–65 years, both sexes, described as healthy | 16 g | 2 weeks | 34 |
| Consumption of Galacto-Oligosaccharides Increases Iron Absorption from Ferrous Fumarate: A Stable Iron Isotope Study in Iron-Depleted Young Women 2019 · Daily GOS consumption · Iron-depleted young women | 15 g | 4 weeks | 34 |
| Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial 2020 · intervention · Adult women with type 2 diabetes mellitus | 10 g | 8 weeks | 33 |
| Prebiotic supplementation modulates advanced glycation end-products (AGEs), soluble receptor for AGEs (sRAGE), and cardiometabolic risk factors through improving metabolic endotoxemia: a randomized-controlled clinical trial 2020 · intervention · Adult women with type 2 diabetes mellitus | 10 g | 8 weeks | 33 |
| β2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults 2016 · β2-1 fructan · Healthy adult men and women | 15 g | 4 weeks | 30 |
| Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial 2015 · intervention group · Women with type 2 diabetes | 10 g | 8 weeks | 30 |
| A randomized controlled trial on the efficacy of resistant dextrin, as functional food, in women with type 2 diabetes: Targeting the hypothalamic-pituitary-adrenal axis and immune system 2018 · intervention group · Women with type 2 diabetes mellitus | 10 g | 8 weeks | 30 |
| The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial 2022 · intervention group · Adults over 18 with stage 3–5 chronic kidney disease attending a predialysis clinic; predominantly female | 13.5 g | 14 weeks | 30 |
| A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults 2025 · Low Dose 2′-FL arm · Healthy adults aged 60–83.9 years, both sexes | 1 g | 6 weeks | 30 |
| Effects of wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal parameters in healthy preadolescent children 2014 · WBE 5.0 g/day · Healthy children aged 8–12 years | 5 g | 3 weeks | 29 |
| A human milk oligosaccharide alters the microbiome, circulating hormones, and metabolites in a randomized controlled trial of older adults 2025 · High Dose 2′-FL arm · Healthy adults aged 60–83.9 years, both sexes | 5 g | 6 weeks | 29 |
| Consumption of Solnul(™) Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial 2023 · Low dose (3.5 g RPS combined with 3.5 g digestible corn starch) · Healthy adults aged 18–69 years | 3.5 g | 4 weeks | 25 |
| Consumption of Solnul(™) Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial 2023 · High dose (7 g RPS) · Healthy adults aged 18–69 years | 7 g | 4 weeks | 25 |
| Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial 2023 · OF · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety | 8 g | 4 weeks | 24 |
| Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial 2023 · 2’FL · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety | 2 g | 4 weeks | 24 |
| β2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial 2012 · β2-1 fructans (Orafti® Synergy1) · Healthy adults aged 45–65 years | 8 g | 4 weeks | 22 |
| Relative abundance of the Prevotella genus within the human gut microbiota of elderly volunteers determines the inter-individual responses to dietary supplementation with wheat bran arabinoxylan-oligosaccharides 2020 · Wheat bran AXOS supplement · Men and women aged 60 years and above, BMI 20–32 kg/m², free-living elderly volunteers | 15 g | 10 days | 21 |
| Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis 2011 · GBF group · Patients with ulcerative colitis in remission | 30 g | 60 days | 20 |
| Wheat bran extract alters colonic fermentation and microbial composition, but does not affect faecal water toxicity: a randomised controlled trial in healthy subjects 2015 · WBE · Healthy subjects | 10 g | 3 weeks | 20 |
| Oligofructose decreases serum lipopolysaccharide and plasminogen activator inhibitor-1 in adults with overweight/obesity 2017 · oligofructose · Adults with overweight or obesity | 21 g | 12 weeks | 20 |
| Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts 2021 · kestose group · Healthy men and women aged 20–64 years with BMI ≥23 kg/m², mostly overweight or obese; participants with treated diabetes and specified abnormal metabolic measures were excluded. | 10 g | 12 weeks | 20 |
| A low-dose prebiotic fiber supplement reduces lipopolysaccharide-binding protein concentrations in a subgroup of young, healthy adults consuming low-fiber diets 2025 · prebiotic fiber mix · Healthy adults aged 18–45 years, men and women, BMI 23–32 kg/m², habitually consuming less than 15 g fiber per day | 12 g | 4 weeks | 20 |
| Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women 2015 · Flaxseed mucilage · Women aged 40–70 years, postmenopausal for at least 1 year, with obesity (BMI 30–45 kg/m²) | 10 g | 6 weeks | 19 |
| Effects of Prebiotics vs a Diet Low in FODMAPs in Patients With Functional Gut Disorders 2018 · prebiotic group · Patients with functional gastrointestinal disorders and flatulence; age and sex not reported | 2.8 g | 4 weeks | 19 |
| 2'-Fucosyllactose supplementation results in a transient improvement in gut microbial resilience after vancomycin use in adults with overweight or obesity: a randomized, double-blind, placebo-controlled intervention 2025 · 2′-FL group · Adults aged 20–65 years with overweight or obesity (BMI 25–40 kg/m²), without impaired fasting glucose or impaired glucose tolerance | 12 g | 8 weeks | 18 |
| Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier 2018 · 15 g/d AX · Overweight and obese subjects | 15 g | 6 weeks | 17 |
| Reversible aberrancies in gut microbiome of moderate and late preterm infants: results from a randomized, controlled trial 2023 · Preterm Prebiotic · Moderate and late preterm neonates born at 32+0 to 36+6 weeks’ gestation, birth weight greater than 1500 g, enrolled at 1–3 days old | 600 mg | 60 days | 17 |
| Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier 2018 · 7.5 g/d AX · Overweight and obese subjects | 7.5 g | 6 weeks | 16 |
| Effects of 1-kestose on microbiome changes caused by vonoprazan: a randomized, double-blind, placebo-controlled pilot study 2024 · 1-kestose group · Patients scheduled to undergo endoscopic resection for superficial gastroduodenal tumors | 10 g | 8 weeks | 16 |
| A prebiotic intervention study in children with autism spectrum disorders (ASDs) 2018 · B-GOS® group · Children aged 4–11 years with diagnosed autism spectrum disorder; some followed an exclusion diet and others an unrestricted diet | 1.8 g | 6 weeks | 13 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · 2′FL 5 g · Healthy adults aged 18–60 years, male and female | 5 g | 2 weeks | 10 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · 2′FL 10 g · Healthy adults aged 18–60 years, male and female | 10 g | 2 weeks | 10 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · 2′FL 20 g · Healthy adults aged 18–60 years, male and female | 20 g | 2 weeks | 10 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · LNnT 5 g · Healthy adults aged 18–60 years, male and female | 5 g | 2 weeks | 10 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · LNnT 10 g · Healthy adults aged 18–60 years, male and female | 10 g | 2 weeks | 10 |
| Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota 2016 · LNnT 20 g · Healthy adults aged 18–60 years, male and female | 20 g | 2 weeks | 10 |
| The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers 2004 · prebiotic · Healthy human volunteers; age and sex not stated | 20 g | 2 weeks | 9 |
| Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment 2014 · GOS · Healthy adults aged 18–45 years with normal BMI receiving amoxicillin treatment | 7.5 g | 12 days | 6 |
| Time-Restricted Eating and Prebiotic Supplementation Demonstrate Feasibility and Acceptability in Young Adult Pediatric Cancer Survivors: A Randomized Controlled Pilot Trial 2025 · 8-h TRE plus prebiotic supplement (PreTRE) · Young adults aged 18–39 who had completed treatment for pediatric cancer and had overweight or obesity | 2.75 g | 12 weeks | 6 |
| Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial 2012 · group III: the prebiotic · Adults aged 18–65 with HIV infection, antiretroviral-treatment-naïve, CDC stage A or B, and CD4+ count >350 cells/mm³ | 10 g | 16 weeks | 5 |
| Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans 2004 · lactulose group · Healthy volunteers; age and sex not reported | 10 g | 6 weeks | — |
| Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial 2006 · GOS/FOS group · Fully formula-fed infants aged 4 to 6 months starting solid foods | 4.5 g | 6 weeks | — |
| Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology 2007 · 0:10 sucrose:lactitol group · healthy, non-adapted adults; age and sex not specified | 10 g | 7 days | — |
| Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity--a randomized, double-blind, placebo-controlled study 2007 · GOS/lcFOS group · Pregnant women receiving supplementation from week 25 of gestation until delivery | 9 g | — | — |
| Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study 2008 · Commercial galactooligosaccharide, 7 g/d · Healthy human volunteers; age and sex not reported | 7 g | 7 days | — |
| Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study 2008 · Novel galactooligosaccharide, 3.6 g/d · Healthy human volunteers; age and sex not reported | 3.6 g | 7 days | — |
| Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study 2008 · Novel galactooligosaccharide, 7 g/d · Healthy human volunteers; age and sex not reported | 7 g | 7 days | — |
| A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans 2008 · 15 g resistant maltodextrin · Healthy adult humans | 15 g | 3 weeks | — |
| Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers 2008 · B-GOS treatment · Healthy elderly volunteers; age range and sex not specified | 5.5 g | 10 weeks | — |
| Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome 2009 · 3.5 g/d prebiotic · Patients with Rome II positive irritable bowel syndrome | 3.5 g | 12 weeks | — |
| Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome 2009 · 7 g/d prebiotic · Patients with Rome II positive irritable bowel syndrome | 7 g | 12 weeks | — |
| Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal 2009 · prebiotic group · Healthy adult men and women | 16 g | 2 weeks | — |
| Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study 2010 · WGM cereal · Healthy men and women, mean age 32 years | 48 g | 3 weeks | — |
| The effect of pre- and probiotics on the colonic ammonia metabolism in humans as measured by lactose-[¹⁵N₂]ureide 2010 · wrinkle pea starch (WPS) · Healthy adults aged 20–28 years | 30 g | 10 days | — |
| Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial 2011 · 15 g/day prebiotic group · HAART-naive adults with HIV-1 infection; age and sex not specified | 15 g | 12 weeks | — |
| Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial 2011 · 30 g/day prebiotic group · HAART-naive adults with HIV-1 infection; age and sex not specified | 30 g | 12 weeks | — |
| A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age 2012 · GOS · Men and women aged 50 years and above | 8 g | 3 weeks | — |
| Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects 2012 · polydextrose (PDX) · healthy human subjects | 8 g | — | — |
| Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties 2012 · XOS · Healthy volunteers | 5 g | 4 weeks | — |
| Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers 2012 · WR(+) bread · Healthy volunteers; age and sex not specified | 2.14 g | 3 weeks | — |
| Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial 2013 · 2·5 g GOS group · Healthy girls aged 10–13 years | 5 g | 3 weeks | — |
| Galacto-oligosaccharides increase calcium absorption and gut bifidobacteria in young girls: a double-blind cross-over trial 2013 · 5 g GOS group · Healthy girls aged 10–13 years | 10 g | 3 weeks | — |
| Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota 2014 · 1.4 g XOS group · Healthy adult subjects | 1.4 g | 8 weeks | — |
| Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota 2014 · 2.8 g XOS group · Healthy adult subjects | 2.8 g | 8 weeks | — |
| [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption] 2018 · FOS group · Healthy volunteers; age and sex not reported | 16 g | 9 days | — |
| [A machine learning model based on initial gut microbiome data for predicting changes of Bifidobacterium after prebiotics consumption] 2018 · GOS group · Healthy volunteers; age and sex not reported | 16 g | 9 days | — |
| Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial 2019 · prebiotic (FOS) group · Adults aged 18–80 years with nondiabetic non-dialysis-dependent chronic kidney disease and eGFR <45 mL/min/1.73 m² | 12 g | 90 days | — |
| Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics 2018 · GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²) | 5 g | 3 weeks | — |
| Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial 2018 · resistant starch · Adults receiving hemodialysis with chronic kidney disease; age and sex not reported | 8 g | 4 weeks | — |
| Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults 2019 · Litesse® Ultra™ polydextrose (LU) · Overweight or obese adults | 12 g | 26 weeks | — |
| A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora 2019 · D1 · Healthy adults aged 18–55 years | 2.5 g | 90 days | — |
| A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora 2019 · D2 · Healthy adults aged 18–55 years | 5 g | 90 days | — |
| A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora 2019 · D3 · Healthy adults aged 18–55 years | 10 g | 90 days | — |
| Resistant starch supplementation attenuates inflammation in hemodialysis patients: a pilot study 2020 · RS group · Adults with chronic kidney disease receiving hemodialysis; mean age 55.3 years; 56% men | 16 g | 4 weeks | — |
| Prebiotic potencial of juçara berry on changes in gut bacteria and acetate of individuals with obesity 2020 · juçara group · Adults aged 31–59 years, both sexes, with obesity classes I and II | 5 g | 6 weeks | — |
| Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial 2021 · YBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors | 500 mg | 5 weeks | — |
| Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial 2021 · SBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors | 500 mg | 5 weeks | — |
| Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial 2021 · OBG · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors | 10 g | 5 weeks | — |
| Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial 2021 · AX · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors | 10 g | 5 weeks | — |
| Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial 2021 · EPS · Men and postmenopausal women aged 50–79 years, community-dwelling and willing to receive seasonal influenza vaccination; healthy seniors | 2.3 g | 5 weeks | — |
| Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19 2022 · low-dose inulin · Adults aged 18 years or older hospitalized with moderate COVID-19, free from chronic GI symptoms at baseline, and given broad-spectrum antibiotics | 16 g | 7 days | — |
| Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients With Persistent Mental Health and Gastrointestinal Symptoms After COVID-19 2022 · high-dose inulin · Adults aged 18 years or older hospitalized with moderate COVID-19, free from chronic GI symptoms at baseline, and given broad-spectrum antibiotics | 32 g | 7 days | — |
| Effects of dragon fruit oligosaccharides on immunity, gut microbiome, and their metabolites in healthy adults - A randomized double-blind placebo controlled study 2023 · 4 g/day DFO group · Healthy adults | 4 g | 4 weeks | — |
| Effects of dragon fruit oligosaccharides on immunity, gut microbiome, and their metabolites in healthy adults - A randomized double-blind placebo controlled study 2023 · 8 g/day DFO group · Healthy adults | 8 g | 4 weeks | — |
| Maternal prebiotic supplementation during pregnancy and lactation modifies the microbiome and short chain fatty acid profile of both mother and infant 2024 · prebiotic group · Pregnant women who continued supplementation during lactation; their infants were also assessed | 14.2 g | — | — |
| The Effects of Prebiotic Supplementation on Markers of Exercise-Induced Gastrointestinal Syndrome in Response to Exertional Heat Stress 2025 · PREBIOTIC · Endurance athletes; age and sex not reported | 16 g | 8 weeks | — |
| Iron absorption and loss, and efficacy of iron supplementation with and without prebiotics in children with virally suppressed HIV: three prospective studies in South Africa 2025 · iron + GOS · children aged 10–15 years with virally suppressed HIV and iron deficiency | 7.5 g | 12 weeks | 42 |
| Maternal Human Milk Oligosaccharide Profile Modulates the Impact of an Intervention with Iron and Galacto-Oligosaccharides in Kenyan Infants 2019 · FeGOS group · Generally healthy infants aged 6.5–9.5 months; no stated diagnosed condition | 10.5 g | 120 days | 25 |
| Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants 2024 · 7.5-g+iron group · Kenyan infants | 7.5 g | 3 weeks | — |
| Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants 2024 · 3-g+iron group · Kenyan infants | 3 g | 3 weeks | — |
| Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease 2018 · sitagliptin-synbiotic group (group 2) · Adults aged 18–60 with nonalcoholic fatty liver disease, BMI 25–29.9, and impaired fasting glucose and/or impaired glucose tolerance | 500 mg | 16 weeks | 70 |
| Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple-Blind, Placebo-Controlled Trial 2022 · synbiotic · Adults with metabolic syndrome; age range and sex distribution not specified | 77 g | 12 weeks | 65 |
| Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease 2020 · synbiotic treatment · Adults with proven nonalcoholic fatty liver disease (NAFLD); ages and sex distribution not specified for this arm | 8 g | 1 year | 55 |
| Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial 2023 · Synbiotic · Healthy adults aged 18–65 years; 66% female in this arm; no stated disease | 500 mg | 8 weeks | 53 |
| Effects of Synbiotic Supplementation on Chronic Inflammation and the Gut Microbiota in Obese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study 2021 · synbiotic group · Adults aged 30 to under 80 years with obesity and type 2 diabetes mellitus | 7.5 g | 24 weeks | 45 |
| Yacon syrup reduces postprandial glycemic response to breakfast: A randomized, crossover, double-blind clinical trial 2019 · Intervention B · Adult women, including normal-weight and grade I obese participants | 14 g | 1 day | 40 |
| Previous gut microbiota has an effect on postprandial insulin response after intervention with yacon syrup as a source of fructooligosaccharides: a randomized, crossover, double-blind clinical trial 2023 · yacon syrup intervention (intervention A) · young adult women | 14 g | 1 day | 40 |
| The effects of synbiotics on indoxyl sulphate level, constipation, and quality of life associated with constipation in chronic haemodialysis patients: a randomized controlled trial 2022 · Synbiotics · Adults over 18 years old with chronic kidney disease on haemodialysis and gastrointestinal complaints including constipation | 60 mg | 60 days | 30 |
| The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial 2023 · Synbiotic group · Adults aged 25–65, women and men with subclinical hypothyroidism treated with levothyroxine | 500 mg | 10 weeks | 28 |
| Red Raspberry and Fructo-Oligosaccharide Supplementation, Metabolic Biomarkers, and the Gut Microbiota in Adults with Prediabetes: A Randomized Crossover Clinical Trial 2022 · RRB + FOS · Adults with prediabetes and insulin resistance | 8 g | 4 weeks | 26 |
| Inulin-type fructans and 2'fucosyllactose alter both microbial composition and appear to alleviate stress-induced mood state in a working population compared to placebo (maltodextrin): the EFFICAD Trial, a randomized, controlled trial 2023 · OF/2’FL · Adults aged 18–50, men and women, with mild-to-moderately elevated stress and anxiety | 10 g | 4 weeks | 24 |
| Changes in Gut Microbiota and Systemic Inflammation after Synbiotic Supplementation in Patients with Systemic Lupus Erythematosus: A Randomized, Double-Blind, Placebo-Controlled Trial 2022 · synbiotic-supplemented group · Women aged 18–60 with systemic lupus erythematosus and gastrointestinal symptoms | 80 mg | 60 days | 23 |
| Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial 2014 · synbiotic · Healthy volunteers; age and sex not reported. | 5 g | 3 weeks | 18 |
| Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients 2011 · Group I (inulin, FOS and ALA enriched cookie) · Obese patients; age and sex not specified | 3.1 g | 30 days | 15 |
| Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection 2012 · Synbiotic · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl | 2.5 g | 4 weeks | 14 |
| Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection 2012 · Fiber-only · Adult women with HIV-1 infection taking antiretroviral medication and with blood CD4 count >200 cells/μl | 2.5 g | 4 weeks | 13 |
| Effects of Synbiotic Supplement on Human Gut Microbiota, Body Composition and Weight Loss in Obesity 2020 · synbiotic (treatment) group · Adult men and women, mean age 47.4 years, initially overweight or obese (mean BMI 33.5 kg/m²), enrolled in a weight-loss program; participants with gastrointestinal, autoimmune or metabolic diseases and relevant medications were excluded. | 5.5 g | 90 days | 10 |
| Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2) 2020 · Synbiotic NATUREN G · Adults aged 30–65 with stage V chronic kidney disease receiving hemodialysis | 10 g | 8 weeks | 7 |
| Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial 2012 · group II: the synbiotic · Adults aged 18–65 with HIV infection, antiretroviral-treatment-naïve, CDC stage A or B, and CD4+ count >350 cells/mm³ | 10 g | 16 weeks | 5 |
| In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own 2008 · LGG plus GOS · Healthy school-aged children | 2 g | 3 weeks | — |
| A novel resistant maltodextrin alters gastrointestinal tolerance factors, fecal characteristics, and fecal microbiota in healthy adult humans 2008 · 7.5 g maltodextrin plus 7.5 g resistant maltodextrin · Healthy adult humans | 7.5 g | 3 weeks | — |
| Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota 2009 · sc-FOS+extract group · Healthy volunteers aged 22–51, men and women, with no stated condition | 5 g | 30 days | — |
| Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol 2012 · synbiotic dietary supplement · healthy elderly volunteers | 10 g | 2 weeks | — |
| Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties 2012 · INU-XOS · Healthy volunteers | 1 g | 4 weeks | — |
| Freeze-dried powdered yacon: effects of FOS on serum glucose, lipids and intestinal transit in the elderly 2014 · supplement group · Elderly men and women, mean age 67.11 ± 6.11 years | 7.4 g | 9 weeks | — |
| An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention 2016 · LAB4 · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon | 55.8 mg | 90 days | — |
| Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics 2018 · IVS-1 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²) | 5 g | 3 weeks | — |
| Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics 2018 · BB-12 + GOS · Women and men aged 18–65 years with obesity (BMI 30.0–40.0 kg/m²) | 5 g | 3 weeks | — |
| Probiotic or synbiotic alters the gut microbiota and metabolism in a randomised controlled trial of weight management in overweight adults 2019 · LU+B420 · Overweight or obese adults | 12 g | 26 weeks | — |
| Plasma and Urinary (Poly)phenolic Profiles after 4-Week Red Raspberry (Rubus idaeus L.) Intake with or without Fructo-Oligosaccharide Supplementation 2020 · RRB+FOS · Men and women aged 20–60 years; participants with prediabetes and insulin resistance and metabolically healthy reference participants | 8 g | 4 weeks | — |
| Multi-species synbiotic supplementation increased fecal short chain fatty acids and anti-inflammatory cytokine interleukin-10 in adult men with dyslipidemia; A randomized, double-blind, clinical trial 2024 · synbiotic group · Adult men with dyslipidemia | 10 g | 12 weeks | — |
| Effects of multi-species synbiotic supplementation on circulating miR-27a, miR-33a levels and lipid parameters in adult men with dyslipidaemia; a randomised, double-blind, placebo-controlled clinical trial 2025 · synbiotic · adult men with dyslipidaemia | 10 g | 12 weeks | — |
| The anti-inflammatory effects of three different dietary supplement interventions 2025 · Synbiotic arm · Adults aged 18 years and older with BMI 20–39.9 | 10 g | 6 weeks | — |
| The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial 2024 · synbiotic group · Adults aged 30–70 with chronic heart failure, LVEF <40%, and NYHA class I–III | 38.5 mg | 10 weeks | 45 |
| Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial 2024 · Intervention group, H2-SIBO · Adults with diagnosed hydrogen SIBO | 5 g | 90 days | 32 |
| The association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot study 2017 · Flortec group · Men with idiopathic oligoasthenoteratospermia (iAOT) and no chromosomal aberrations | 1.94 g | 26 weeks | 20 |
| Characterizing gut microbial dysbiosis and exploring the effect of prebiotic fiber supplementation in patients with COPD 2025 · nutritional supplement group · Adults with moderate to very severe, clinically stable COPD (GOLD II–IV); ages reported as 69.3 ± 7.4 years | 6 g | 90 days | 16 |
| An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients 2021 · Synbiotic (arm S), CKD patients · Adults aged 30–65 with stage IIIb–IV chronic kidney disease, not on dialysis | 5 g | 60 days | 13 |
| An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients 2021 · Synbiotic (arm S), healthy volunteers · Healthy adults aged 35–60 | 5 g | 60 days | 12 |
| An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effects of a Multi-Strain Probiotic/Prebiotic, Antioxidant Intervention 2016 · LAB4 ANTI · Recreationally active adults aged about 35 years, 25 men and 5 women in the overall study cohort, training for their first long-distance triathlon | 55.8 mg | 90 days | — |
| Effects of a Synbiotic on Plasma Immune Activity Markers and Short-Chain Fatty Acids in Children and Adults with ADHD-A Randomized Controlled Trial 2023 · Synbiotic 2000 · Children and adults aged 5–55 with ADHD | 10 g | 9 weeks | — |